Corbus Pharmaceuticals Holdings, Inc. announced an underwritten public offering of 4,744,231 shares at $13.00 each and 1,025,000 pre-funded warrants on October 30, 2025, expecting to raise about $70.5 million from the offering which will close on or around November 3, 2025.